» Articles » PMID: 25880599

MiR-454 is Down-regulated in Osteosarcomas and Suppresses Cell Proliferation and Invasion by Directly Targeting C-Met

Overview
Journal Cell Prolif
Date 2015 Apr 17
PMID 25880599
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Osteosarcoma is the most common primary bone malignancy of children and young adults. Increasing evidence has shown that microRNAs (miRNAs) are associated with cancer development, but, little is known concerning the role of miR-454 in osteosarcoma.

Materials And Methods: qRT-PCR was performed to detect expression of miR-454 in osteosarcoma cell lines and tissues. To understand its role in osteosarcoma, we reintroduced expression of miR-454 in the MG-63 cell line by transfection with miR-454 mimics or inhibitors. CCK-8 assay and an invasion assay were used to detect the functional role of miR-454. Luciferase assay and western blot analysis were performed to detect the target gene of miR-454.

Results: miR-454 was found to be down-regulated in osteosarcoma tissues and cell lines. Its over-expression inhibited tumour growth and invasion and its down-regulation promoted cell proliferation and invasion. Subsequent investigation revealed that c-Met was a direct and functional target of miR-454 in osteosarcoma. Overexpression of miR-454 impaired c-Met-induced cell proliferation and invasion. Finally, miR-454 was found to be inversely correlated to c-Met expression in human osteosarcoma tissues.

Conclusions: Reduced-expression of miR-454 in osteosarcoma cells promoted tumour growth by targeting c-Met, thus miR-454 may be a potential therapy target for this tumour.

Citing Articles

MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3.

Li N, Fu J, Wang Q, Rao Q, Yao L, Shao X Ren Fail. 2024; 46(2):2394635.

PMID: 39192609 PMC: 11360635. DOI: 10.1080/0886022X.2024.2394635.


Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.

Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L Int J Mol Sci. 2023; 24(10).

PMID: 37240338 PMC: 10219319. DOI: 10.3390/ijms24108993.


Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells.

Tang W, Zhang Y, Zhang H, Zhang Y Cancers (Basel). 2022; 14(24).

PMID: 36551686 PMC: 9776923. DOI: 10.3390/cancers14246201.


The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents.

Grundy M, Narendran A Front Pediatr. 2022; 10:910268.

PMID: 36034555 PMC: 9399617. DOI: 10.3389/fped.2022.910268.


miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.

Sbirkov Y, Vergov B, Mehterov N, Sarafian V Int J Mol Sci. 2022; 23(9).

PMID: 35563051 PMC: 9103677. DOI: 10.3390/ijms23094657.


References
1.
Bonuccelli G, Avnet S, Grisendi G, Salerno M, Granchi D, Dominici M . Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. Oncotarget. 2014; 5(17):7575-88. PMC: 4202145. DOI: 10.18632/oncotarget.2243. View

2.
Ohdaira H, Sekiguchi M, Miyata K, Yoshida K . MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif. 2011; 45(1):32-8. PMC: 6496138. DOI: 10.1111/j.1365-2184.2011.00798.x. View

3.
Huang J, Zhang S, Gao Y, Liu Y, Liu Y, Zhao Z . MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014; 47(4):277-86. PMC: 6496620. DOI: 10.1111/cpr.12109. View

4.
Zhang S, Liu L, Wang R, Tuo H, Guo Y, Yi L . MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A. PLoS One. 2013; 8(12):e83620. PMC: 3869804. DOI: 10.1371/journal.pone.0083620. View

5.
Namlos H, Meza-Zepeda L, Baroy T, Ostensen I, Kresse S, Kuijjer M . Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012; 7(10):e48086. PMC: 3485010. DOI: 10.1371/journal.pone.0048086. View